On day 1, the alcoholic patients had, in general, concentrations of HDL that were markedly higher [ 11 1.7 f 32.0 mg/100 ml ( m e a n f s .~. ) ; range 65.0-136.8 mg/100 ml] than control subjects (61.7k 11.0 mg/100 ml; range 45.7-71.1 mg/100 ml), but which fell (P<0.01) to within the normal range between 6 and 9 days after withdrawal (Fig. 1 ). These changes were most marked in the HDL, component (measured by precipitation) which decreased from 62.6f23.3 mg/100 ml to 20.0k12.2 mg/100 ml. The HDLzh subfraction decreased from 35.1 k 19.6% of the total HDL fraction to 18.1 k 11.5%, while the HDL,, subfraction remained approximately constant. VLDL showed no marked change during the withdrawal period. The mean concentration of LDL at day 1 (75.0 k 24.0 mg/ I 0 0 ml) was lower than normal control values and increased to a mean concentration of 120.2 k 25.3 mg/100 ml which is within the normal range.
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For control subjects, the concentrations of all lipoprotein fractions remained constant to within f 7.5% of their mean values over the 15 day period.
There was no change in the gross composition of phospholipids or fatty acids in the erythrocyte membranes of the alcoholic patients during the 15 days following alcohol withdrawal; the values at day 1 showed no depletion in the concentrations of docosahexaenoic acid (22 :6, n -3) (3.0 f 1.6%) or eicosapentaenoic acid (20 : 5, n -3) ( 1.33 k 0.28%) in comparison with normal subjects I S ] . These observations do not, however, preclude the possibility of alterations in the distribution of the different phospholipid classes within the microenvironment of the cell membranes.
These results suggest that high lipoprotein lipase activity in alcoholic patients results in an increased rate of lipolysis of VLDL, whose synthesis is increased by alcoholic intake 171. Elevated HDL, levels are, therefore, likely to have arisen through the increased transfer of VLDL degradation products to HDL. These findings are consistent with studies on the effect of alcohol treatment on plasma lipoproteins [ 8 ] .
This study thus provides a demonstration in vivo that HDL,,, and not HDL,,, is the subfraction of HDL, implicated in the lipolytic process. It also revealed that at least 7-9 days are required after alcohol withdrawal for lipoprotein concentrations to reach normal levels. densities and include the high-density lipoprotein [ 31 and low-density lipoprotein (LDL) [4] . The inhibitory effect of LDL on thromboplastin has been linked to its association with other inhibitory proteins [2] . In the present study, the ability of apolipoprotein B, the protein component of LDL, to inhibit thromboplastin activity was investigated. The effect of lipid peroxidation on the reconstituted apolipoprotein B was also examined, since it was demonstrated 151 that the parent lipoprotein may undergo alterations due to lipid peroxidation, resulting in the loss and even the reversal of its inhibitory effect towards thromboplastin.
BaS0,-adsorbable proteins and lipoproteins from serum were prepared using a modification of the method described by Prydz [6] . Human serum (200 ml) was stirred with X-ray 633rd MEETING, LONDON grade BaSO, (20 g) (BDH Fine Chemicals, Poole, U.K.) for 45 min, at room temperature. After centrifugation at 2000 g for 15 min, the BaSO, sediment was washed three times with 100 ml of sodium acetate/acetic acid ( 1 M ) buffer, pH 4.95, and was centrifuged at 4°C after each wash, as before. Adsorbed proteins and lipoproteins were eluted from the BaSO, with two separate 25 ml aliquots of sodium citrate (5X,, w/v) and, after centrifugation, propyl gallate ( 5 ,UM) was added to the eluate, as an antioxidant. After dialysis against distilled water to remove the citrate, the BaSO, eluate was freeze-dried and then delipidated by stirring for 30 min at -20"C, with five 6 0 ml aliquots of various chloroform/ methanol mixtures (1 :2; 1 : 2 ; 1: 1; 2 : 1; 2: I; v/v). The delipidated protein residue was resuspended in 2 ml of 8 Murea, to dissolve other proteins, except apolipoprotein B, which was then solubilized at room temperature in 1.5 ml of 2.6Y0 (w/v) SDS in 0.01 M-Tris/HCI buffer, pH 8.0, containing 0.0 1% (w/v) sodium azide. To isolate the apolipoprotein €3, this solution was then fractionated as described by Mills et ul. [7] on a gel-filtration column containing 100 ml of Sephacryl S-200 (Pharmacia Ltd, Milton Keynes, U.K.) equilibrated and eluted with 0.52% (w/v) SDS in 0.01 M-Tris/ HCI buffer, pH 8.0, containing 0.0001'% (w/v) sodium azide. The primary peak containing the apolipoprotein B was collected and concentrated to approximately 1 ml by ultrafiltration. Although not homogeneous, when examined by electrophoresis o n a 12% (w/v) SDS/polyacrylamide gel, the presence of apolipoprotein B was confirmed by crossedimmunoclectrophoresis o n a 1'% (w/v) agarose gel.
The apolipoprotein B ( I mg/ml) was relipidated by incubation at 37°C for 1 h with soya bean lecithin (1 mg/ml) (Sigma Chemical Co. Ltd, Poole, U.K.), previously dispersed with sodium deoxycholate (0.25%, w/v). The effect of this relipidated protein on thromboplastin activity was examined after incubation with a 1 in 200 dilution of rabbit brain thromboplastin solution (Diagnostic Reagents, Thame, Oxon.. U.K.) and assaying for residual thromboplastin activity by means of the one-stage prothrombin time-test. To investigate the effect of lipid peroxidation on any ability of relipidated apolipoprotein B to inhibit thromboplastin, an aliquot was dialysed separately in the presence of Cu2+ ions
In another experiment, the apolipoprotein was reconstituted ( 1 mg/ml) with lipid mixtures more representative of those present in the native lipoproteins, including soya bean lecithin ( 1 mg/ml), triolein (0.5 mg/ml) and cholesterol oleate (2.5 mg/ml). An aliquot of this was also dialysed as before, in the presence of Cu-+ ions ( 10 p~) , except that there was a continuous flow of oxygen through the solution. The ability of all of these systems to inhibit thromboplastin was assayed as before against suitable lipid controls devoid of apolipo-
protein B. The extent of lipid peroxidation was also monitored as malondialdehyde (MDA) using the thiobarbituric acid test.
The apolipoprotein B inhibited the thromboplastin activity by 80% when it was reconstituted in soya bean lecithin alone and this was not altered by dialysis in the presence of Cu2+ ions. On the other hand, after reconstitution with the full complement of lipids, i.e. lecithin, triolein and cholesteryl oleate, dialysis in the presence of Cu?+ ions changed its behaviour towards thromboplastin activity. This was reversed from a level of 60% inhibition, in the undialysed preparation, to an enhancement of the thromboplastin activity by 135% after dialysis. Conversely, it was also noted that the addition of peroxidized lipids, in the absence of apolipoprotein B, reduced thromboplastin activity by 54%. Typically, the concentration of MDA rose from 2 0 ,UM to 50 ,UM after the dialysis treatment to inducc lipid peroxidation and when the apolipoprotein B was present the electrophoretic mobility of the reconstituted lipoprotein-like complex increased.
In conclusion, the ability of the reconstituted apolipoprotein B to influence thromboplastin activity was found to be variable and depended especially on whether the system had been subjected to conditions which induce lipid peroxidation. This finding agrees with the results obtained previously using native LDL [ 5 ] and although there is no complete explanation the variations in the ability of apolipoprotein B to associate with different amounts and cl lipids is a determining factor. Thus, by altering the a apolipoprotein B to associate with various lipids, lipid peroxidation may ultimately affect the interaction between apolipoprotein B and thromboplastin. Consequently, an increase in the oxidation of LDL irt vivo may indirectly influence the activity of thromboplastin and its ability to induce the hypercoagulable state leading to thrombus formation.
glutaminase have been identified, one of which is the tissue transglutaminase which is thought to be involved in a number of calcium-mediated cytoskeletal processes important t o cell membrane functions . This transglutaminase appears to exist in two forms: a soluble cytosolic enzyme and an insoluble membrane-associated enzyme [ 51.
It has been observed that, when compared with their normal equivalents, neoplastic tissues show decreased levels of transglutaminase activity [6, 71 , and that further reductions in activity occurring within the primary tumour may be associated with the phenotypic alterations necessary for tumour progression and metastasis [8, 91. More recent work
